Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb Medical Dialogues Bureau11 April 2020 1:56 PM IST USA: A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent infringement...
Gilead's drug leads global race to find virus treatment Medical Dialogues Bureau26 Feb 2020 2:24 PM ISTBeijing | Tokyo: China will release results at the end of April from clinical trials of a Gilead Sciences drug that is emerging as a frontrunner in...
Regeneron partners with US to develop treatment for coronavirus Medical Dialogues Bureau7 Feb 2020 9:30 AM ISTUS: The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has...
NPPA pulls Gilead on price exemption plea for its Hepatitis B drug Farhat Nasim4 Feb 2020 3:12 PM ISTNew Delhi: The apex drug price regulator, National Pharmaceuticals Pricing Authority (NPPA) has recently sought clarifications from the US-drugmaker...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 2:48 PM ISTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
Merck loses bid to revive over Rs 18 crore patent verdict against Gilead Farhat Nasim31 Oct 2019 3:27 PM ISTIn 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
Gilead licenses respiratory, herpes antiviral research programs from Novartis Medical Dialogues Bureau23 July 2019 9:15 AM ISTUnder the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report Medical Dialogues Bureau15 July 2019 9:30 AM ISTThe deal is the largest Gilead has executed since new Chief Executive Officer Dan O'Day took the reins in March as he attempts to bolster the San...
Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project Medical Dialogues Bureau12 July 2019 9:10 AM ISTEstablished in 1987 and headquartered in California, Gilead Sciences is one of the top 10 pharmaceutical companies in the world. As a pioneer in...
Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension Farhat Nasim30 April 2019 10:00 AM ISTCipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
Novartis Kymriah wins UK backing after initial lymphoma snub Medical Dialogues Bureau3 Feb 2019 10:00 AM IST"Today's positive announcement regarding access to Kymriah treatment in England and Wales was secured as a result of our close working collaboration...
Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict Ruby Khatun Khatun19 Feb 2018 9:45 AM ISTA federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
